Cigna Product — Revenue decreased by 7.4% to $54.04B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.1%, from $48.63B to $54.04B. Over 4 years (FY 2021 to FY 2025), Product — Revenue shows an upward trend with a 15.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates growing market share or higher demand for the segment's offerings, while a decrease may signal competitive pressure, contract losses, or pricing adjustments.
This metric represents the total revenue recognized from the sale of specific products or services within a defined busi...
Comparable to segment-level revenue reporting in other diversified healthcare and pharmacy benefit management firms, though variations exist based on how companies categorize service versus product revenue.
ci_segment_product_revenue_from_contract_with_customer| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $30.05B | $31.01B | $32.33B | $30.70B | $31.97B | $32.76B | $33.14B | $32.14B | $33.96B | $34.53B | $36.60B | $42.04B | $45.10B | $48.28B | $49.94B | $48.63B | $53.65B | $56.05B | $58.34B | $54.04B |
| QoQ Change | — | +3.2% | +4.2% | -5.0% | +4.2% | +2.5% | +1.1% | -3.0% | +5.7% | +1.7% | +6.0% | +14.8% | +7.3% | +7.1% | +3.4% | -2.6% | +10.3% | +4.5% | +4.1% | -7.4% |
| YoY Change | — | — | — | — | +6.4% | +5.6% | +2.5% | +4.7% | +6.2% | +5.4% | +10.5% | +30.8% | +32.8% | +39.8% | +36.4% | +15.7% | +19.0% | +16.1% | +16.8% | +11.1% |